RxSIGHT, INC.(RXST)

26.38-0.29-1.11%

Market data delayed 15 minutes

    • ShayBoloor
      ·
      01-02

      My Small-cap Portfolio & the Reasons Behind Each of my Holdings as we Head into 2025

      Here’s an inside look at my small-cap portfolio & the reasons behind each of my holdings as we head into 2025 🧐• $AST SpaceMobile, Inc.(ASTS)$ -- The American Tower of Space, building a global satellite-to-cellphone network to address the $1T+ connectivity market.• $Rocket Lab USA, Inc.(RKLB)$ -- The FedEx of Space, providing end-to-end satellite launch, manufacturing & space data solutions for the $400B space economy.• $IONQ Inc.(IONQ)$ -- Positioning itself as a leader in quantum computing by offering scalable, trapped-ion quantum systems for high-value use cases such as drug discovery, logistics optimization & financial modeling -- addressing a pro
      My Small-cap Portfolio & the Reasons Behind Each of my Holdings as we Head into 2025
      TOP随风668: This article is good. Forward it to Tiger Friends and have a look. Several of them have doubled in a short time.
      2
      Report
      Capital_Insights
      ·
      2024-02-27

      13F Season: 11 Sectors Highest $ Inflows Based on the Last 13F Filings

      13F Filings for the December 31, 2023 Quarter are due 2024-02-14, 7338 filings already imported!What is a 13F filing?The Securities and Exchange Commission's (SEC) Form 13F is a quarterly report that is required to be filed by all institutional investment managers with at least $100 million in assets under management. It discloses their equity holdings and can provide insights into what the smart money is doing in the market.Below are a thread about the Top 100 tickers with the highest $ inflows based on the last 13F filings, organized by sector: Basic Materials Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Healthcare Industrials Real Estate Technology UtilitiesTop 100 Holdings in Basic Materials Ranked By Fund Flow Across All 13F Filings, 2023-12-31
      13F Season: 11 Sectors Highest $ Inflows Based on the Last 13F Filings
      Comment
      Report
      Value_investing
      ·
      2023-12-19

      BTIG is particularly bullish on ABT, GKOS, ZBH, IRTC & RXST in 2024

      The medical tech sector of US stocks will be more stable in 2024 with the panic caused by GLP-1 diet drugs, supply chain problems and high interest rates gradually subside, analysts at BTIG said in a report released on Friday.Analysts said the sector may not be able to achieve growth similar to 2023, driven by pent-up demand related to the pandemic, but company profit and loss and supply chain management should improve, and the adverse impact of inflation and prices should be reduced. Still, year-over-year data pressure could be a topic in the first half of 2024.The investment bank also expects the medtech sector to benefit from the 2024 election cycle, saying the sector tends to outperform the $S&P 500(.SPX)$ in election years. BTIG analysts
      BTIG is particularly bullish on ABT, GKOS, ZBH, IRTC & RXST in 2024
      Comment
      Report
      blinkix
      ·
      2022-01-11

      CHECK the NEW financial results of RxSight!!

      Preliminary Unaudited Results Preliminary unaudited fourth quarter 2021 revenue is expected to be approximately $8.4 million, representing growth of approximately 71% compared to the prior year period, driven by: Sale of 45 Light Delivery Devices (LDD™s), expanding the installed base to 206 LDDs as of December 31, 2021; and Sale of 2,959 Light Adjustable Lenses (LAL®s). Preliminary unaudited 2021 fiscal year revenue is expected to be approximately $22.6 million, representing growth of approximately 54% compared to the prior year, driven by: Sale of 114 LDDs; and Sale of 8,328 LALs. Preliminary unaudited cash, cash equivalents and short-term investments as of December 31, 2021, is expected to be approximately $159.3 million.
      CHECK the NEW financial results of RxSight!!
      Comment
      Report
    • Company Profile

      Company Name
      RxSIGHT, INC.
      Market
      NASDAQ
      Establishment Date
      - -
      Employees
      - -
      Office Location
      - -
      Zip Code
      - -
      Phone
      - -
      Fax
      - -
      Introduction
      RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
    • 1D
    • 5D
    • Day
    • Week
    • Month
    Loading ...
    High
    26.81
    Open
    26.39
    Volume%
    0.76
    Low
    26.26
    Close
    26.67
    T/O Rate
    0.64%
    errorbox banner

    抱歉,当前请求异常(-1)

    Company: TTMF Limited. Tech supported by Xiangshang Yixin.

    Email:uservice@ttm.financial